Document Detail

RIFLE is alive: long live RIFLE.
Jump to Full Text
MedLine Citation:
PMID:  23190722     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
ABSTRACT: Diagnosis and classification of acute kidney injury was addressed systematically only 8 years ago when the classification called RIFLE (acronym of Risk, Injury, Failure, Loss of function and End stage Kidney disease describing progressive severity of renal damage) was created. Since then, several studies have tried to apply, validate, criticize and modify this initial scheme: as a matter of fact, RIFLE is today one of the most appreciated and utilized medical classification systems worldwide. After an initial period of epidemiological research, it is acceptable to apply it now at the bedside, following both urine output and creatinine criteria, with the purpose of routinely monitoring renal function of critically ill patients.
Authors:
Zaccaria Ricci
Publication Detail:
Type:  EDITORIAL     Date:  2012-11-29
Journal Detail:
Title:  Critical care (London, England)     Volume:  16     ISSN:  1466-609X     ISO Abbreviation:  Crit Care     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9801902     Medline TA:  Crit Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  182     Citation Subset:  -    
Affiliation:
Pediatric Cardiac Anesthesia/Intensive Care Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital, IRCCS, Piazza S, Onofrio 4, 00165, Rome, Italy. z.ricci@libero.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Crit Care
Journal ID (iso-abbrev): Crit Care
ISSN: 1364-8535
ISSN: 1466-609X
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2012 BioMed Central Ltd
Print publication date: Year: 2012
Electronic publication date: Day: 29 Month: 11 Year: 2012
pmc-release publication date: Day: 29 Month: 11 Year: 2013
Volume: 16 Issue: 6
First Page: 182 Last Page: 182
PubMed Id: 23190722
ID: 3672589
Publisher Id: cc11851
DOI: 10.1186/cc11851

RIFLE is alive: long live RIFLE
Zaccaria Ricci1 Email: z.ricci@libero.it
1Pediatric Cardiac Anesthesia/Intensive Care Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy

The past

The RIFLE criteria were born in Vicenza (Italy) back in 2004 when a group of smart clinicians realized that none of them was able to provide the same definition of acute kidney injury (AKI), formerly known as acute renal failure [1]. Aware of their unique expertise in the field of renal disorders in critically ill patients, these pioneers had the winning idea of creating the first definition of acute renal disease on the basis of one commonsense rule: to work, such a definition has to be universally utilized and, hence, based on just two, simple and easily available parameters, serum creatinine and urine output. A second innovation was to consider renal damage as a spectrum of severities that could be easily classified (even though only by convention rather than by strict clinical relevance) into three classes (risk, injury and failure) and two outcomes (loss of function and end stage kidney disease). The final chapter of this story is that hundreds of authors tried to apply and eventually validated the RIFLE criteria with epidemiological studies on AKI [2]. It has to be noted that a 'definition' should not be confounded with the concept of 'aetiological diagnosis': RIFLE criteria were not born to identify the cause of AKI but only to identify it in a standardized way. Consequently, a renewed interest in AKI diagnosis, prevention and treatment was raised by this huge amount of standardized information [3]: today, awareness of actual AKI incidence and of its lethal effects (even after milder forms of renal impairment) in several clinical settings has dramatically increased and some centers have already implemented RIFLE score in their databases and medical records [4]. The other side of the coin was that, even if sometimes unintentionally, each study tended to slightly modify the original RIFLE definition in order to best adapt it to its research [5]. To cite just a few, in retrospective epidemiological studies, urine output (UO) criteria have been discarded because this kind of data is not easily achievable in databases [5]. In other cases, baseline creatinine (essential in RIFLE scoring) has been argued about, estimated or not evaluated because it is not available for all patients [5]. Some authors have finally verified the RIFLE criteria on large cohorts of critically ill patients for very short periods of time, such as the first 24 hours after ICU admission [5]. It must be acknowledged that this variation may have significantly affected findings on AKI prevalence, incidence and prognosis.


The present

In the previous issue of Critical Care Wlodzimirow and coworkers [6] show in a prospective observational study how RIFLE criteria should be correctly used. They substantially simulated routine use of RIFLE classification with UO criteria (RIFLE serum creatinine (sCr)+UO) and without UO criteria (RIFLE sCr) for a whole week after ICU admission. The authors also included patients without known pre-ICU creatinine and estimated it, assuggested by RIFLE, with the Modification of Diet in Renal Disease formula [1]. According to their findings, the use of RIFLE without the urine criteria significantly underscores the incidence and grade of AKI, significantly delays the diagnosis of AKI and underestimates mortality rates. Remarkably, the accurate analysis by Wlodzimirow and colleagues reveals that AKI diagnosis during the first week of ICU admission was doubled by RIFLE sCr+UO,probably due to transient periods of oliguria not followed by increases in creatinine level. Interestingly, Prowle and coauthors [7], driven by a similar idea, recently concluded that oliguria (<0.5 ml/kg/h) is a modest predictor of subsequent creatinine increase, especially when lasting for shorter periods of time (<12 hours). This aspect should be taken into account in clinical practice and, obviously, AKI should not be classified after 30 minutes of anuria: as a matter of fact, the UO-Risk class of RIFLE needs at least 6 hours of oliguria before the criterion is reached. However, UO is by far one of the earliest clinical signs of acute renal impairment. Furthermore, we know that subclinical AKI, either identified by pathological levels of early biomarkers (such as neutrophil gelatinaseassociated lipocalin) [8], or by transient azotemia (defined as rapidly recovering AKI with return to no-AKI RIFLE class within 72 hours of onset) [9] is indeed associated with poor outcomes. On the other hand, creatinine alone may underscore the severity of AKI, due to its delayed increase in the setting of rapidly evolving AKI, especially in patients with fluid overload and hemodilution [10]. Alertness to milder forms of AKI, those with the potential of worsening and that should be targeted by specific treatment, is one of the most important goals of the RIFLE classification.


Conclusion: the future?

RIFLE is an imperfect, questionable, conventional, practical definition. The original aim of its creators was not to predict mortality or to associate it with any hard clinical outcome, but to find a common language on AKI diagnosis. Still, clinical validation was performed and it achieved satisfactory results. New criteria [11,12] have been proposed as substitutes of RIFLE in an attempt to improve the sensitivity and specificity of the AKI identification: they apparently failed to achieve significant results [5]. It should be considered whether a fi ne-tuning of the original RIFLE criteria might have worked better. Moreover, as an exclusively personal opinion, RIFLE customizations and new classifications might have induced confusion and uncertainty in readers and clinicians, those originally intended to be the main users of such criteria. It must be remembered that the acute respiratory distress syndrome definition, born under the same rationale as RIFLE (but many years earlier), has been recently modified after about two decades of worldwide application [13,14].

In conclusion, the time has come to apply RIFLE clinically, at the bedside, applying both UO and creatinine criteria [9], with the purpose of longitudinally monitoring the renal condition of critically ill patients.

The next step of RIFLE will be to understand if it is actually possible to standardize AKI prevention strategies or therapeutic approaches to the different severity classes: early attempts have already been performed with success [15].


Abbreviations

AKI: acute kidney injury; RIFLE: Risk: Injury: Failure: Loss of function and End stage Kidney disease; sCr: serum creatinine; UO: urine output.


Competing interests

The author declares that they have no competing interests.


References
Bellomo R,Ronco C,Kellum JA,Mehta RL,Palevsky P,Acute Dialysis Quality Initiative workgroupAcute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupCrit CareYear: 200416R20421210.1186/cc287215312219
Ricci Z,Cruz D,Ronco C,The RIFLE criteria and mortality in acute kidney injury: A systematic reviewKidney IntYear: 20081653854610.1038/sj.ki.500274318160961
Basso F,Ricci Z,Cruz D,Ronco C,International survey on the management of acute kidney injury in critically ill patients: year 2007Blood PurifYear: 20101621422010.1159/00032012620948196
Colpaert K,Hoste E,Van Hoecke S,Vandijck D,Danneels C,Steurbaut K,De Turck F,Decruyenaere J,Implementation of a real-time electronic alert based on the RIFLE criteria for acute kidney injury in ICU patientsActa Clin Belg SupplYear: 20071632232518283992
Cruz DN,Ricci Z,Ronco C,Clinical review: RIFLE and AKIN - time for reappraisalCrit CareYear: 20091621110.1186/cc775919638179
Wlodzimirow KA,Abu-Hanna A,Slabbekoorn M,Chamuleau RA,Schultz MJ,Bouman CS,A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically illsCrit CareYear: 201216R20010.1186/cc1180823078781
Prowle JR,Liu YL,Licari E,Bagshaw SM,Egi M,Haase M,Haase-Fielitz A,Kellum JA,Cruz D,Ronco C,Tsutsui K,Uchino S,Bellomo R,Oliguria as predictive biomarker of acute kidney injury in critically ill patientsCrit CareYear: 201116R17210.1186/cc1031821771324
Haase M,Devarajan P,Haase-Fielitz A,Bellomo R,Cruz DN,Wagener G,Krawczeski CD,Koyner JL,Murray P,Zappitelli M,Goldstein SL,Makris K,Ronco C,Martensson J,Martling CR,Venge P,Siew E,Ware LB,Ikizler TA,Mertens PR,The outcome of neutrophil gelatinase-associated lipocalinpositive subclinical acute kidney injury: a multicenter pooled analysis of prospective studiesJ Am Coll CardiolYear: 2011161752176110.1016/j.jacc.2010.11.05121511111
Uchino S,Bellomo R,Bagshaw SM,Goldsmith D,Transient azotaemia is associated with a high risk of death in hospitalized patientsNephrol Dial TransplantYear: 2010161833183910.1093/ndt/gfp62420054022
Macedo E,Bouchard J,Soroko SH,Chertow GM,Himmelfarb J,Ikizler TA,Paganini EP,Mehta RL,Program to Improve Care in Acute Renal Disease StudyFluid accumulation, recognition and staging of acute kidney injury in critically-ill patientsCrit CareYear: 201016R8210.1186/cc900420459609
Mehta RL,Kellum JA,Shah SV,Molitoris BA,Ronco C,Warnock DG,Levin A,Acute Kidney Injury NetworkAcute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCrit CareYear: 200716R3110.1186/cc571317331245
The ad-hoc working group of ERBPFliser D,Laville M,Covic A,Fouque D,Vanholder R,Juillard L,Van Biesen W,A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathyNephrol Dial TransplantYear: 2012 in press .
Bernard GR,Artigas A,Brigham KL,Carlet J,Falke K,Hudson L,Lamy M,Legall JR,Morris A,Spragg R,The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordinationAm J Respir Crit Care MedYear: 1994168188247509706
ARDS Definition Task Force,Ranieri VM,Rubenfeld GD,Thompson BT,Ferguson ND,Caldwell E,Fan E,Camporota L,Slutsky AS,Acute respiratory distress syndrome: the Berlin DefinitionJAMAYear: 2012162526253322797452
Colpaert K,Hoste EA,Steurbaut K,Benoit D,Van Hoecke S,De Turck F,Decruyenaere J,Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE classCrit Care MedYear: 2012161164117010.1097/CCM.0b013e3182387a6b22067631

Article Categories:
  • Commentary


Previous Document:  Difference Between Critical Care Initiation Anion Gap and Prehospital Admission Anion Gap is Predict...
Next Document:  A self-cleaning porous TiO(2)-Ag core-shell nanocomposite material for surface-enhanced Raman scatte...